---
document_datetime: 2023-09-21 18:21:25
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/infanrix-penta-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: infanrix-penta-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 1.4052998
conversion_datetime: 2025-12-23 04:52:49.876098
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Steps taken after granting the Marketing Authorisation

For procedures finalised after 01 November 2002 please refer to module 8B.

| Scope                                                                          | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amen ded on   |
|--------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|------------------------------------------|
| Change in batch size of active substance                                       | I/II0001             | I/II                     | 25.01.01                            | 22.11.01                                 |
| Quality change (demonstration of TSE compliance)                               | II/0002              | II                       | 15.11.01                            | -                                        |
| Changes to comply with supplements to pharmacopoeias                           | I/0003               | I                        | 23.03.01                            | 22.11.01                                 |
| Change in test procedures of the medicinal product                             | I/II/0004            | I/II                     | 26.04.01                            | -                                        |
| Extension of shelf-life as foreseen at time of authorisation                   | I/0005               | I                        | 26.03.01                            | 16.07.01                                 |
| Change(s) to the test method(s) and/or specifications for the active substance | II/0006              | II                       | 23.08.01                            | 24.09.01                                 |
| Quality changes                                                                | II/0007              | II                       | 20.09.01                            | 02.10.01                                 |
| Change in name of manufacturing site                                           | I/0008               | I                        | 16.11.01                            | -                                        |
| Change in the name of MAH and manufacturer responsible for batch release       | I/0009               | I                        | 05.11.01                            | -                                        |
| Change in pack size for a medicinal product                                    | I/0010               | I                        | 07.11.01                            | -                                        |
| Change in pack size for a medicinal product                                    | I/0011               | I                        | 07.11.01                            | -                                        |
| Change in name of manufacturing site                                           | I/0012               | I                        | 16.11.01                            | -                                        |
| Change(s) to the test method(s) and/or specifications for the finished product | II/0013              | II                       | 30.05.02                            | 07.06.02                                 |
| Change in container shape                                                      | I/0014               | I                        | 20.09.02                            | 27.09.02                                 |
| Changes to the Patient Leaflet regarding some MAH local representative details | N/0015               | N                        | 19.09.02                            | 08.10.02                                 |

T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 of 7 November 1996.

Medicinal product no longer authorised Change in batch size of active substance Quality change (demonstration of TSE compliance) Changes to comply with supplements to pharmacopoeias Change in test procedures of the medicinal product Extension of shelf-life as foreseen at time of authorisation Change(s) to the test method(s) and/or specifications for the active substance Quality changes Change in name of manufacturing site Change in the name of MAH and manufacturer responsible for batch release Change in pack size for a medicinal product Change in pack size for a medicinal product Change in name of manufacturing site Change(s) to the test method(s) and/or specifications for the finished product Change in container shape Changes to the Patient Leaflet regarding some MAH  local representative details 1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application.

N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 March 1992.

2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification date. The Commission Decision will be amended accordingly.